Skip to content Skip to footer
Infliximab-Axxq: Benefits, Reviews, Info, Side Effects!
Rx Details
Infliximab-Axxq
Remicade, Inflectra, Renflexis
Infliximab
Prescription
Biologic
Drugs
Prescription Only
Infliximab-Axxq is a medication used to treat various inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriasis, and ankylosing spondylitis. The benefits of Infliximab-Axxq include reducing inflammation, relieving symptoms such as pain and swelling, improving quality of life, and potentially slowing down disease progression. It can also help reduce the need for other medications or surgeries in some cases.
Abdominal Pain, Back Pain, Cough, Dizziness, Fatigue, Fever, Headache, Infections, Infusion-Related Reactions, Nausea, Rash
Infliximab-Axxq is a biosimilar to infliximab, which is a monoclonal antibody used to treat various autoimmune diseases. The dosage of infliximab can vary depending on the condition being treated, the patient’s weight, and the specific treatment protocol prescribed by a healthcare provider. For conditions like rheumatoid arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, and psoriatic arthritis, the typical starting dose is often 5 mg/kg administered as an intravenous infusion. The frequency and duration of subsequent doses can vary, often starting with infusions at weeks 0, 2, and 6, followed by maintenance infusions every 8 weeks. It’s important to note that the exact dosage and schedule should be determined by a healthcare professional based on individual patient needs and response to treatment. Always consult with a healthcare provider for specific medical advice and before starting any new treatment.
Rheumatoid arthritis, crohn’s disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis
Safety profile of Infliximab-Axxq is generally favorable.
No Interactions Reported
$1,000 – $2,000
$1200-$2,500 per vial.

A Synopsis of

Infliximab-Axxq

Infliximab-Axxq is a medication that belongs to a class of drugs known as tumor necrosis factor (TNF) inhibitors. It is used to treat a variety of inflammatory conditions, including rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriasis, and ankylosing spondylitis.

This medication works by targeting and blocking TNF, a protein in the body that plays a key role in the inflammatory response. By inhibiting TNF, Infliximab-Axxq helps to reduce inflammation and alleviate symptoms associated with these conditions.

It is important to note that Infliximab-Axxq is typically administered through intravenous infusion in a medical setting. The dosage and frequency of infusions will vary depending on the specific condition being treated and the individual patient’s response to the medication.

As with any medication, there are potential side effects associated with Infliximab-Axxq. These can include infusion reactions, increased risk of infections, liver problems, and a slightly increased risk of certain types of cancer. It is important to discuss these risks with your healthcare provider before starting treatment with Infliximab-Axxq.

Overall, Infliximab-Axxq can be a highly effective treatment option for individuals suffering from inflammatory conditions. It is important to work closely with your healthcare provider to determine if this medication is right for you and to monitor for any potential side effects while on treatment. If you have any questions or concerns about Infliximab-Axxq, do not hesitate to reach out to your healthcare provider for more information.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN